Isabel Botella

Isabel Botella's work experience includes:

- Jazz Pharmaceuticals (2022-present): Neuroscience Medical Lead and previously held the role of Medical Advisor Senior Manager.

- GW Pharmaceuticals plc (2018-2021): Medical Advisor Senior Manager and Medical Science Liaison involved in the pre-launch and launch of a new rare disease medication and leading the Early Access Program in Spain.

- Amife (2018-2022): Coordinadora Grupo de Trabajo MSL AMIFE, providing a platform for the development and advancement of medical professionals in the pharmaceutical industry.

- Teva Pharmaceuticals (2017-2018): MSL Neurociencias.

- Stallergenes Greer (2015-2017): Medical Advisor & MSL responsible for providing scientific information to healthcare professionals and acting as a reference point for the sales team.

- SynteractHCR (Asignado a GSK) (2014-2015): Técnico de Información Científica responsible for providing authorized and validated scientific information about GSK products to all departments and healthcare professionals.

- GlaxoSmithKline (2013-2014): Selling Excellence Training-SET TRAINEE involved in providing scientific support to the sales team and preparing training materials.

- Farmacia (2011-2012): Pharmacist responsible for dispensing medications, managing the pharmacy, and patient follow-up.

- La Fugitiva libreria (2010-2011): Encargada.

Isabel Botella's education history is as follows:

From 2005 to 2011, Isabel Botella studied at the Universidad Complutense de Madrid, earning a degree in Farmacia.

In 2009 to 2010, they attended the Université Claude Bernard Lyon 1, specializing in Farmacia.

Isabel Botella pursued further education in 2014, obtaining a degree in Máster I+D del Medicamento from the Universidad Autónoma de Madrid.

Continuing their academic journey, they enrolled in the Universidad de Alcalá in 2015 and completed a Máster en Farmacoepidemiología y Farmacovigilancia in 2016.

As of May 2023, Isabel Botella has also obtained a certification in "How to Stop Wasting Time in Meetings" from LinkedIn.